首页 | 本学科首页   官方微博 | 高级检索  
     

不同放疗剂量对局部晚期肺癌患者近远期疗效、血清肿瘤标志物水平与不良反应发生率的影响
引用本文:易琼,倪峰,邰国梅,钱霞,谭程,郭京. 不同放疗剂量对局部晚期肺癌患者近远期疗效、血清肿瘤标志物水平与不良反应发生率的影响[J]. 临床和实验医学杂志, 2021, 20(1): 32-35
作者姓名:易琼  倪峰  邰国梅  钱霞  谭程  郭京
作者单位:南通大学附属肿瘤医院(南通市肿瘤医院)放疗科 江苏 南通 226361;南通大学附属肿瘤医院(南通市肿瘤医院)放疗科 江苏 南通 226361;南通大学附属肿瘤医院(南通市肿瘤医院)放疗科 江苏 南通 226361;南通大学附属肿瘤医院(南通市肿瘤医院)放疗科 江苏 南通 226361;南通大学附属肿瘤医院(南通市肿瘤医院)放疗科 江苏 南通 226361;南通大学附属肿瘤医院(南通市肿瘤医院)放疗科 江苏 南通 226361
基金项目:江苏省南通市科技项目(编号:MS12018096);江苏省科技计划项目(编号:BE2017679)。
摘    要:目的 探究不同放疗剂量对局部晚期肺癌患者近远期疗效、血清肿瘤标志物水平与不良反应发生率的影响.方法 前瞻性选取2014年1月至2017年11月南通市肿瘤医院收治的接受放疗的局部晚期肺癌患者60例.根据随机数字表法分为高剂量组(n=31)和低剂量组(n=29),高剂量给予等效生物剂量为76~86 Gy,低剂量为60~66...

关 键 词:局部晚期肺癌  放疗剂量  近远期疗效  血清肿瘤标志物  不良反应

Effects of different doses of radiotherapy on the short-term and long-term efficacy,serum tumor marker levels and adverse reactions rate in locally advanced lung cancer patients
Affiliation:(Department of Radiotherapy,Nantong University Affiliated Tumor Hospital/Nantong Tumor Hospital,Nantong Jiangsu 226361,China)
Abstract:Objective To explore the effects of different doses of radiotherapy on the short-and long-term efficacy,serum tumor marker levels and adverse reactions rate in locally advanced lung cancer patients.Methods Between January 2014 to November 2017,60 patients with locally advanced lung cancer who received radiotherapy were selected form Nantong Tumor Hospital.According to the random number table method,they were divided into high-dose group(31 cases,76~86 Gy)and low-dose group(29 cases,60~66 Gy).The short-and long-term efficacy,serum tumor marker levels[carcinoembryonic Antigen(CEA),carbohydrate carcinoma antigen(CA125),neuron specific enolase(NSE)and cytokeratin fragment(CYFRA21-1)]and adverse reactions rate were analyzed in the two groups.Results In terms of the total effective rate of 74.19%in the high-dose group and 65.52%in the low-dose group,there was no statistically significant difference(P>0.05).The survival rate of the high-dose group was higher than that of the low-dose group(87.10%vs.82.76%),while the recurrence rate and metastasis rate were 9.68% and 9.68%,which were lower than the low-dose group(13.79%vs.13.79%),there was no statistically significant difference between the two groups(P>0.05).The levels of carcinoembryonic antigen(CEA),carbohydrate antigen(CA125),neuron-specific enolase(NSE)and cytokeratin fragment(CYFRA21-1)after radiotherapy were lower than before radiotherapy(P<0.001);high-dose group was higher than low-dose group[(45.63±7.33)ng/mLvs.(26.46±7.93)ng/mL,(80.66±5.95)U/mL vs.(45.83±5.77)U/mL,(9.22±2.66)ng/mL vs.(5.23±2.25)ng/mL,(24.24±5.57)ng/mL vs.(21.24±5.69)ng/mL],and the differences were statistically significant(P<0.05).The incidence of adverse reactions in the high-dose group was 22.58%,which was significantly higher than the low-dose group 10.34%,and the difference was statistically significant(P<0.05).Conclusion There is no statistically significant difference between the high and low dose groups in the short-term and long-term efficacy for locally advanced lung cancer patients,but the low dose improves the serum tumor marker levels better than the high dose with less adverse reaction and high safety.
Keywords:Locally advanced lung cancer  Radiotherapy dose  Short-term and long-term efficacy  Serum tumor markers  Adverse reactions
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号